This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2007 Sep;13(9):1018-9.

doi: 10.1038/nm0907-1018.

Schizophrenia drug says goodbye to dopamine

Daniel R Weinberger

PMID: 17828217
DOI: 10.1038/nm0907-1018

Comment

Schizophrenia drug says goodbye to dopamine

Daniel R Weinberger. Nat Med. 2007 Sep.

. 2007 Sep;13(9):1018-9.

doi: 10.1038/nm0907-1018.

Author

Daniel R Weinberger

PMID: 17828217
DOI: 10.1038/nm0907-1018

No abstract available

PubMed Disclaimer

Comment in

Glutamate agonists for schizophrenia stimulate dopamine D2High receptors.
Seeman P. Seeman P. Schizophr Res. 2008 Feb;99(1-3):373-4. doi: 10.1016/j.schres.2007.11.007. Schizophr Res. 2008. PMID: 18077139 No abstract available.

Comment on

Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial.
Patil ST, Zhang L, Martenyi F, Lowe SL, Jackson KA, Andreev BV, Avedisova AS, Bardenstein LM, Gurovich IY, Morozova MA, Mosolov SN, Neznanov NG, Reznik AM, Smulevich AB, Tochilov VA, Johnson BG, Monn JA, Schoepp DD. Patil ST, et al. Nat Med. 2007 Sep;13(9):1102-7. doi: 10.1038/nm1632. Epub 2007 Sep 2. Nat Med. 2007. PMID: 17767166 Clinical Trial.

Similar articles

Schizophrenia therapy: beyond atypical antipsychotics.
Snyder EM, Murphy MR. Snyder EM, et al. Nat Rev Drug Discov. 2008 Jun;7(6):471-2. doi: 10.1038/nrd2571. Epub 2008 May 16. Nat Rev Drug Discov. 2008. PMID: 18483482 No abstract available.
Positive allosteric modulators of the metabotropic glutamate receptor 2 for the treatment of schizophrenia.
Fraley ME. Fraley ME. Expert Opin Ther Pat. 2009 Sep;19(9):1259-75. doi: 10.1517/13543770903045009. Expert Opin Ther Pat. 2009. PMID: 19552508 Review.
Dopamine and its relation to schizophrenia and antipsychotic drugs.
Tarnoff GM. Tarnoff GM. Bull Menninger Clin. 1978 Jul;42(4):321-38. Bull Menninger Clin. 1978. PMID: 29683 No abstract available.
Metabotropic glutamate receptors as targets for novel antipsychotic treatments.
Gray LJ, Hannan AJ, Zhang X. Gray LJ, et al. Curr Pharm Biotechnol. 2012 Jun;13(8):1522-34. doi: 10.2174/138920112800784817. Curr Pharm Biotechnol. 2012. PMID: 22283756 Review.
Receptor pair for schizophrenia.
Sealfon SC, González-Maeso J. Sealfon SC, et al. Pediatr Res. 2008 Jul;64(1):1. doi: 10.1203/PDR.0b013e318180052a. Pediatr Res. 2008. PMID: 18574404 Free PMC article. No abstract available.

See all similar articles

Cited by

Perspectives on the mGluR2/3 agonists as a therapeutic target for schizophrenia: Still promising or a dead end?
Li ML, Hu XQ, Li F, Gao WJ. Li ML, et al. Prog Neuropsychopharmacol Biol Psychiatry. 2015 Jul 3;60:66-76. doi: 10.1016/j.pnpbp.2015.02.012. Epub 2015 Feb 24. Prog Neuropsychopharmacol Biol Psychiatry. 2015. PMID: 25724760 Free PMC article. Review.
[Progress in locating the genetic causes of schizophrenia].
Mössner R, Maier W, Rujescu D. Mössner R, et al. Nervenarzt. 2009 Jan;80(1):6, 8, 10-1. doi: 10.1007/s00115-008-2614-z. Nervenarzt. 2009. PMID: 19132332 Review. German.
Preclinical evaluation of the antipsychotic potential of the mGlu2-positive allosteric modulator JNJ-40411813.
Lavreysen H, Langlois X, Donck LV, Nuñez JM, Pype S, Lütjens R, Megens A. Lavreysen H, et al. Pharmacol Res Perspect. 2015 Mar;3(2):e00097. doi: 10.1002/prp2.97. Epub 2015 Jan 30. Pharmacol Res Perspect. 2015. PMID: 25692027 Free PMC article.
Reversal of cognitive deficits by an ampakine (CX516) and sertindole in two animal models of schizophrenia--sub-chronic and early postnatal PCP treatment in attentional set-shifting.
Broberg BV, Glenthøj BY, Dias R, Larsen DB, Olsen CK. Broberg BV, et al. Psychopharmacology (Berl). 2009 Nov;206(4):631-40. doi: 10.1007/s00213-009-1540-5. Epub 2009 Apr 24. Psychopharmacology (Berl). 2009. PMID: 19390843
Pharmacogenetics in psychiatry: are we ready for widespread clinical use?
Arranz MJ, Kapur S. Arranz MJ, et al. Schizophr Bull. 2008 Nov;34(6):1130-44. doi: 10.1093/schbul/sbn114. Epub 2008 Aug 27. Schizophr Bull. 2008. PMID: 18753306 Free PMC article. Review.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information